150 related articles for article (PubMed ID: 10850391)
1. On the assessment of drug metabolism by assays of codeine and its main metabolites.
Haffen E; Paintaud G; Berard M; Masuyer C; Bechtel Y; Bechtel PR
Ther Drug Monit; 2000 Jun; 22(3):258-65. PubMed ID: 10850391
[TBL] [Abstract][Full Text] [Related]
2. Determination of codeine and metabolites in plasma and urine using ion-pair high-performance liquid chromatography.
Svensson JO; Yue QY; Säwe J
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):49-55. PubMed ID: 8749251
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of codeine and its seven metabolites in plasma and urine by high-performance liquid chromatography with ultraviolet and electrochemical detection.
He H; Shay SD; Caraco Y; Wood M; Wood AJ
J Chromatogr B Biomed Sci Appl; 1998 Apr; 708(1-2):185-93. PubMed ID: 9653961
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity.
Hedenmalm K; Sundgren M; Granberg K; Spigset O; Dahlqvist R
Ther Drug Monit; 1997 Dec; 19(6):643-9. PubMed ID: 9421105
[TBL] [Abstract][Full Text] [Related]
5. Direct determination of codeine, norcodeine, morphine and normorphine with their corresponding O-glucuronide conjugates by high-performance liquid chromatography with electrochemical detection.
Verwey-van Wissen CP; Koopman-Kimenai PM; Vree TB
J Chromatogr; 1991 Oct; 570(2):309-20. PubMed ID: 1797846
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
[TBL] [Abstract][Full Text] [Related]
7. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths.
Frost J; Løkken TN; Helland A; Nordrum IS; Slørdal L
Forensic Sci Int; 2016 May; 262():128-37. PubMed ID: 26986973
[TBL] [Abstract][Full Text] [Related]
8. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.
Yue QY; Svensson JO; Alm C; Sjöqvist F; Säwe J
Br J Clin Pharmacol; 1989 Dec; 28(6):639-45. PubMed ID: 2611086
[TBL] [Abstract][Full Text] [Related]
9. The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine.
Hasselström J; Yue QY; Säwe J
Eur J Clin Pharmacol; 1997; 53(2):145-8. PubMed ID: 9403287
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.
Yue QY; Hasselström J; Svensson JO; Säwe J
Br J Clin Pharmacol; 1991 Jun; 31(6):635-42. PubMed ID: 1867957
[TBL] [Abstract][Full Text] [Related]
11. Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits.
Oguri K; Hanioka N; Yoshimura H
Xenobiotica; 1990 Jul; 20(7):683-8. PubMed ID: 2238703
[TBL] [Abstract][Full Text] [Related]
12. Functional phenotyping of the CYP2D6 probe drug codeine in the horse.
Gretler SR; Finno CJ; Kass PH; Knych HK
BMC Vet Res; 2021 Feb; 17(1):77. PubMed ID: 33581736
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of codeine in humans.
Vree TB; Verwey-van Wissen CP
Biopharm Drug Dispos; 1992 Aug; 13(6):445-60. PubMed ID: 1391681
[TBL] [Abstract][Full Text] [Related]
14. LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-beta-D-glucuronide, morphine-6-beta-D-glucuronide, and codeine-6-beta-D-glucuronide in human urine.
Murphy CM; Huestis MA
J Mass Spectrom; 2005 Nov; 40(11):1412-6. PubMed ID: 16258895
[TBL] [Abstract][Full Text] [Related]
15. Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease.
Molanaei H; Carrero JJ; Heimbürger O; Nordfors L; Lindholm B; Stenvinkel P; Odar-Cederlöf I; Bertilsson L
Eur J Clin Pharmacol; 2010 Mar; 66(3):269-73. PubMed ID: 19940985
[TBL] [Abstract][Full Text] [Related]
16. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation.
Eckhardt K; Li S; Ammon S; Schänzle G; Mikus G; Eichelbaum M
Pain; 1998 May; 76(1-2):27-33. PubMed ID: 9696456
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators.
Yue QY; Alm C; Svensson JO; Säwe J
Ther Drug Monit; 1997 Oct; 19(5):539-42. PubMed ID: 9357098
[TBL] [Abstract][Full Text] [Related]
18. A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by LC-MS.
Frost J; Løkken TN; Brede WR; Hegstad S; Nordrum IS; Slørdal L
J Anal Toxicol; 2015 Apr; 39(3):203-12. PubMed ID: 25556373
[TBL] [Abstract][Full Text] [Related]
19. Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites.
Lötsch J; Skarke C; Schmidt H; Rohrbacher M; Hofmann U; Schwab M; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):35-48. PubMed ID: 16413240
[TBL] [Abstract][Full Text] [Related]
20. O-demethylation of codeine to morphine inhibited by low-dose levomepromazine.
Vevelstad M; Pettersen S; Tallaksen C; Brørs O
Eur J Clin Pharmacol; 2009 Aug; 65(8):795-801. PubMed ID: 19308365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
